Preston Klassen, MD: Mucosal healing and histological remission in patients with cystic fibrosis with ultrasimod

Preston Klbaden, MD, Head of Research and Development at Arena Pharmaceuticals, discusses the results of a recent randomized, placebo-controlled phase 2 study of mucosal healing and histologic remission in patients with moderate-to-moderate severe per unit UC.